CIPLA price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- CIPLA
- MB Code
- MBEQU5289
- ISIN
- INE059A01026
- BSE code
- 500087
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 6541.2 Cr
- Net profit
- 550.11 Cr
- EPS
- 6.86
- YoY revenue
- -2.80%
Company documents
12 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for CIPLA
Dividend of ₹13.00 per share
Ex-date corporate action
Cipla rose over 7% after Q4FY26 results triggered at least six analyst upgrades; JPMorgan and Citi raised targets on better US pipeline v…
Cipla shares rose after Q4 results showed US sales at $155 million and adjusted EBITDA margins near estimates; board approved a final div…
Cipla reported Q4 net profit fell 55% to Rs 555 crore as revenue declined and expenses rose; the board also announced a dividend, signali…
EPS 6.86 vs est. 9.97
Missed estimates by 31.21%
USFDA on April 24, 2026 placed an import alert on Pharmathen’s Rodopi unit that supplies lanreotide to Cipla (≈22% US share). Cipla warne…
Cipla shares faced multiple downgrades due to a disappointing December quarter, with Jefferies cutting its rating to 'Underperform' and r…
Cipla's Q3 results revealed a 57% drop in net profit to ₹675.8 crore, missing estimates significantly. The stock fell 4.5% on January 23,…
Price returns
Historical performance
Technicals
Indicator consensus